Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Neurology

• Publication date

  1999-01-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1212/WNL.52.2.321PMID 9932951
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of carbamazepine on psychomotor performance in näive subjects

  2004cited by this paper
• Conversion to High Dose Gabapentin Monotherapy in Patients with Medically Refractory Partial Epilepsy

  1998cited by this paper
• Topiramate increases cerebral GABA in healthy humans

  1998cited by this paper
• Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy.

  1997cited by this paper
• Topiramate Monotherapy for Partial Onset Seizures

  1997cited by this paper
• Comparison of the Steady‐State Pharmacokinetics of Topiramate and Valproate in Patients with Epilepsy During Monotherapy and Concomitant Therapy

  1997cited by this paper
• Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold.

  1997cited by this paper
• Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures

  1997cited by this paper
• Double‐Blind, Placebo‐Controlled Trial of Topiramate as Add‐on Therapy in Patients with Refractory Partial Seizures

  1996cited by this paper
• Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages

  1996cited by this paper
• Double‐Blind, Placebo‐Controlled Trial of Topiramate (600 mg Daily) for the Treatment of Refractory Partial Epilepsy

  1996cited by this paper
• Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy.

  1996cited by this paper
• Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages

  1996cited by this paper
• The effect of gabapentin on brain gamma‐aminobutyric acid in patients with epilepsy

  1996cited by this paper
• Effect of valproate on cognitive functioning. Comparison with carbamazepine. The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group.

  1996cited by this paper
• Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.

  1995cited by this paper
• Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults

  1995cited by this paper
• Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group.

  1995cited by this paper
• Lamotrigine Therapy for Partial Seizures: A Multicenter, Placebo‐Controlled, Double‐Blind, Cross‐Over Trial

  1994cited by this paper
• Outcomes of Add‐on Treatment with Lamotrigine in Partial Epilepsy

  1993cited by this paper
• Placebo‐controlled study of the efficacy and safety of lamotrigine in patients with partial seizures

  1993cited by this paper
• Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group.

  1993cited by this paper
• A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group.

  1992cited by this paper
• Neuropsychological Abilities Before and After 5 Years of Stable Antiepileptic Drug Therapy

  1992cited by this paper
• Comparative cognitive effects of carbamazepine and phenytoin in healthy adults

  1991cited by this paper
• Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures.

  1985cited by this paper
• Phenytoin and cognitive function: effects on normal volunteers and implications for epilepsy.

  1981cited by this paper
• Sodium valproate and cognitive functioning in normal volunteers.

  1981cited by this paper
• Evaluating storage, retention, and retrieval in disordered memory and learning

  1974cited by this paper
• Multi-infarct dementia. A cause of mental deterioration in the elderly.

  1974cited by this paper

• Is Topiramate Helpful in the Management of Cocaine Use-Related Psychiatric Comorbidities?

  2025cites this paper
• Time-Dependent Risk of Dementia Following Epilepsy Diagnosis: A Nationwide Cohort Study in South Korea.

  2025cites this paper
• Anti-seizure Medication Induced Cognitive Impairment in Children with Epilepsy: A Narrative Review

  2025cites this paper
• Real-World Use of Phentermine and Topiramate for Adolescent Obesity: Retrospective Effectiveness and Safety Analysis

  2025cites this paper
• Effects of frequently prescribed antiseizure medications on motor vehicle driving performance: Narrative review based on a tiered approach for the assessment of clinically meaningful driving impairment in the Ministry of Health, Labour, and Welfare guideline

  2024cites this paper
• Association between gabapentin use and risk of dementia in adults with chronic pain: A nested case-control study.

  2024cites this paper
• Neurohabilitation of Cognitive Functions in Pediatric Epilepsy Patients through LEGO®-Based Therapy

  2024cites this paper
• Cognitive effect of antiseizure medications in medial temporal lobe epilepsy

  2023cites this paper
• The effect of gabapentin and pregabalin administration on memory in clinical and preclinical studies: a meta-analysis and systematic review

  2023cites this paper
• Cognitive reawakening and improved quality of life achieved after discontinuing 16 years of anti-seizure treatment with topiramate

  2022cites this paper
• The association of gabapentin initiation and neurocognitive changes in older adults with normal cognition

  2022cites this paper
• The impact of perampanel on cognition: A systematic review of studies employing standardized tests in patients with epilepsy.

  2021cites this paper
• Treatment for the Benign Childhood Epilepsy With Centrotemporal Spikes: A Monocentric Study

  2021cites this paper
• Hazardous employment of invalid measures for cognitive outcome assessment: You only see what your test can show you.

  2021cites this paper
• Epilepsy and Cognitive Impairment

  2021cites this paper
• ARE ION CHANNELS POTENTIAL THERAPEUTIC TARGETS FOR PARKINSON'S DISEASE?

  2021cites this paper
• Migraine

  2021cites this paper
• Changes in cognition after introduction or withdrawal of zonisamide versus topiramate in epilepsy patients: A retrospective study using Bayes statistics

  2020cites this paper
• Cognitive, adaptive, and behavioral effects of adjunctive rufinamide in Lennox-Gastaut syndrome: A prospective observational clinical study.

  2020cites this paper
• Assessing various sensorimotor and cognitive functions in people with epilepsy is feasible with robotics.

  2020cites this paper
• Cognitive impairment profile differences in patients with psychogenic non-epileptic seizures and epilepsy patients with generalized seizures

  2020cites this paper
• Iatrogenic (drug induced) cognitive disorders

  2020cites this paper
• A prospective pilot study of cognitive impairment and mood in adults with first seizure, new-onset epilepsy, and newly diagnosed epilepsy at time of initial seizure presentation.

  2020cites this paper
• Efficacy of Cicuta virosa medicinal preparations against pentylenetetrazole-induced seizures.

  2020cites this paper
• Homozygous LAMC3 mutation links to structural and functional changes in visual attention networks

  2019cites this paper
• Substance Use Disorders: Cognitive Sequelae, Behavioral Manifestations, Neuroimaging Correlates, and Novel Interventions

  2019cites this paper
• Impulsiveness as a predictor of topiramate response for cocaine use disorder

  2019cites this paper
• Interventions and cognitive functioning in adults with traumatic spinal cord injuries: a systematic review and meta-analysis

  2019cites this paper
• Carbonic anhydrase enzymes: Likely targets for inhalational anesthetics.

  2019cites this paper
• Evaluation of cognitive functions in migraineurs treated with topiramate.

  2019cites this paper
• Biomarkers of Drug Response and Pharmacoresistance to Epilepsy

  2019cites this paper
• Эпилепсия и когнитивные нарушения: какой антиконвульсант выбрать?

  2019cites this paper
• Pharmaco-fMRI: A Tool to Predict the Response to Antiepileptic Drugs in Epilepsy

  2019cites this paper
• Chapter 12 Epilepsy and Cognition

  2018cites this paper
• Cognitive and behavioral outcomes among seizure-controlled children with partial epilepsy on antiepileptic drug monotherapy

  2018cites this paper
• Real-world assessment of treatment with extended-release topiramate (Trokendi XR®) and comparison with previous immediate-release topiramate treatment.

  2018cites this paper
• Topiramate Extended-Release Options: A Focus on Efficacy and Safety in Epilepsy and Comorbidities:

  2017cites this paper
• Drugs That Disturb Sleep and Wakefulness

  2017cites this paper
• Topiramate in Migraine Prevention: A 2016 Perspective

  2017cites this paper
• Comparative effects of chronic administrations of gabapentin, pregabalin and baclofen on rat memory using object recognition test

  2017cites this paper
• Assessing seizure susceptibility using visual psychophysical tests

  2017cites this paper
• 82 – Behavioral, Cognitive, and Social Aspects of Childhood Epilepsy

  2017cites this paper
• Cognitive and Social Outcomes of Epileptic Encephalopathies.

  2017cites this paper
• Short-term neurocognitive outcomes following anterior temporal lobectomy.

  2016cites this paper
• Clinical Utility of the Mig‐SCog

  2016cites this paper
• Epilepsy, Attention-Deficit/Hyperactivity Disorder and Methylphenidate: Critical Examination of Guiding Evidence.

  2016cites this paper
• Pharmacokinetic‐Pharmacodynamic Modeling of Intravenous and Oral Topiramate and Its Effect on the Symbol‐Digit Modalities Test in Adult Healthy Volunteers

  2016cites this paper
• Treatment of Cognitive Deficits in Epilepsy.

  2016cites this paper
• The Role of Antiepileptic Drugs

  2016cites this paper
• ROAD TRAFFIC, DETERMINATION OF FITNESS TO DRIVE | General

  2016cites this paper
• Pharmaco fMRI: Determining the functional anatomy of the effects of medication

  2016cites this paper
• Comparison of Cognitive Impairment between Patients having Epilepsy and Psychogenic Nonepileptic Seizures.

  2015cites this paper
• The effects of antiepileptic drugs on cognitive functional magnetic resonance imaging.

  2015cites this paper
• Developmentally Delayed Children and Adults

  2015cites this paper
• Rates and predictors of patient-reported cognitive side effects of antiepileptic drugs: An extended follow-up.

  2015cites this paper
• Cognitive effects of Epilepsy Therapies

  2015cites this paper
• [Does medication abuse in patients with chronic migraine influence the effectiveness of preventive treatment with topiramate?].

  2014cites this paper
• Effect of Lamotrigine, Levetiracetam and Phenytoin on Learning and Memory in Albino Rats

  2014cites this paper
• Post-traumatic epilepsy: current and emerging treatment options

  2014cites this paper
• Effects of phenytoin and valproic acid on cognitive functions of Thai epileptic patients: a pilot study.

  2014cites this paper
• Lamotrigine attenuates deficits in synaptic plasticity and accumulation of amyloid plaques in APP/PS1 transgenic mice.

  2014cites this paper
• Manejo farmacológico del trastorno por déficit de atención/hiperactividad con metilfenidato y atomoxetina en un contexto de epilepsia

  2014cites this paper
• Key issues in addressing the comorbidity of attention deficit hyperactivity disorder and pediatric epilepsy.

  2014cites this paper
• Impact of offspring death on cognitive health in late life: the Cache County study.

  2014cites this paper
• El abuso de fármacos en pacientes con migraña crónica influye en la efectividad del tratamiento preventivo con topiramato

  2014cites this paper
• Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically.

  2014cites this paper
• Peripheral nerve injury and gabapentin, but not their combination, impair attentional behavior via direct effects on noradrenergic signaling in the brain

  2014cites this paper
• [Pharmacological management of attention deficit hyperactivity disorder with methylphenidate and atomoxetine within a context of epilepsy].

  2014cites this paper
• Topiramate: Effects on cognition in patients with epilepsy, migraine headache and obesity

  2013cites this paper
• Topiramate in schizophrenia: a review of effects on psychopathology and metabolic parameters.

  2013cites this paper
• Développement atypique du langage dans le contexte de la chirurgie de l'épilepsie chez l'enfant

  2013cites this paper
• [A comparative study of the effectiveness of topiramate and flunarizine in independent series of chronic migraine patients without medication abuse].

  2013cites this paper
• Associations between cognitive performance and cortisol reaction to the DEX/CRH test in patients recovered from depression.

  2013cites this paper
• Влияние антиэпилептических препаратов на когнитивные функции

  2013cites this paper
• Monitoring the cognitive effects of antiepileptic pharmacotherapy--approaching the individual patient.

  2013cites this paper
• Cognitive side-effects of antiepileptic drugs in children.

  2013cites this paper
• Effects of chronic treatment with commonly used antiepileptic drugs on passive avoidance learning in prepubertal rats

  2013cites this paper
• Impaired verbal fluency under topiramate – evidence for synergistic negative effects of epilepsy, topiramate, and polytherapy

  2013cites this paper
• SSRIs versus Non-SSRIs in Post-traumatic Stress Disorder

  2012cites this paper
• Pharmacological approaches in bipolar disorders and the impact on cognition: a critical overview

  2012cites this paper
• Genetic and environmental correlates of topiramate‐induced cognitive impairment

  2012cites this paper
• Topiramate and cognitive impairment: evidence and clinical implications

  2012cites this paper
• Влияние противоэпилептической терапии на течение аффективных расстройств при эпилепсии у женщин

  2012cites this paper
• The effect of topiramate plasma concentration on linguistic behavior, verbal recall and working memory.

  2012cites this paper
• Topiramate and its effect on fMRI of language in patients with right or left temporal lobe epilepsy.

  2012cites this paper
• Mood stabilizers for the treatment of behavioral and psychological symptoms of dementia: An update review

  2012cites this paper
• EVALUATION OF THE MOOD-STABILIZERS ASSOCIATED NEUROCOGNITIVE EFFECTS IN BIPOLAR PATIENTS THERAPEUTICAL PRACTICE

  2012cites this paper
• Effect of Antiepileptic Drugs on Cognitive Function in Individuals with Epilepsy

  2012cites this paper
• Chapter 46 – Drugs That Disturb Sleep and Wakefulness

  2011cites this paper
• Lacosamide: Novel action mechanisms and emerging targets in epilepsy and pain

  2011cites this paper
• Clobazam as an adjunctive therapy in treating seizures associated with Lennox–Gastaut syndrome

  2011cites this paper
• The effect of pain on cognitive function: a review of clinical and preclinical research.

  2011cites this paper
• Gender and drug effects on neuroimaging in epilepsy

  2011cites this paper
• Newly diagnosed epilepsy: Cognitive outcome after 12 months

  2011cites this paper
• Cognitive effects of topiramate revealed by standardised low-resolution brain electromagnetic tomography (sLORETA) of event-related potentials.

  2010cites this paper
• Behavioral and cognitive effects of anti-epileptic drugs.

  2010cites this paper
• Seizure and Cognitive Outcomes in Children and Adolescents with Epilepsy Treated with Topiramate

  2010cites this paper
• Cognitive effects of topiramate in migraine patients aged 12 through 17 years.

  2010cites this paper
• Psychopharmaka und Fahrtüchtigkeit

  2010cites this paper
• Topiramate-induced depression in cases using topiramate for migraine prophylaxis

  2010cites this paper